Evidence map›Paper›PMID 20718815›Full record

ArticleClinical and translational science2010

Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines.

Allan R Brasier, Sundar Victor, Hyunsu Ju, William W Busse, Douglas Curran-Everett, Eugene Bleecker, Mario Castro, Kian Fan Chung, Benjamin Gaston, Elliot Israel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and translational science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Article
  3. Protein-Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Article
  4. Review
  5. Current Insights on the Impact of Proteomics in Respiratory Allergies.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Response to Parenteral Triamcinolone in Severe Asthma: A Useful Induced Phenotype for Clinicians?American journal of respiratory and critical care medicine · 2021
    Article
  10. Review
  11. Article
  12. Omics for the future in asthma.Seminars in immunopathology · 2020
    Review
  13. Article
  14. Airway and serum biochemical correlates of refractory neutrophilic asthma.The Journal of allergy and clinical immunology · 2017
    Article
  15. Asthma biomarkers in the age of biologics.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2017
    Review
  16. Asthma heterogeneity and severity.The World Allergy Organization journal · 2016
    Review
  17. Monitoring asthma in childhood.European respiratory review : an official journal of the European Respiratory Society · 2015
    Article
  18. Molecular classification of outcomes from dengue virus -3 infections.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2015
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 2 countries.

Allan R BrasierSealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, USA. arbrasie@utmb.edu
Sundar Victor
Hyunsu Ju
William W Busse
Douglas Curran-Everett
Eugene Bleecker
Mario Castro
Kian Fan Chung
Benjamin Gaston
Elliot Israel
Sally E Wenzel
Serpil C Erzurum
Nizar N Jarjour
William J Calhoun
Galveston College · USUniversity of Wisconsin–Madison · USBrigham and Women's Hospital · USCleveland Clinic · USImperial College London · GBNational Jewish Health · USThe University of Texas Medical Branch at Galveston · USUniversity of Pittsburgh · USUniversity of Virginia · USWake Forest University · USWashington University in St. Louis · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BOLDOGH, ISTVAN STEVEN · 2005 to 2022
$23.9M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Tissue and Cell Processing CoreU19AI070489 · NIAID · WASHINGTON UNIVERSITY · PI HOLTZMAN, MICHAEL J · 2006 to 2016
$17.9M
UTMB CLINICAL AND TRANSLATIONAL SCIENCE AWARD: NASA BED REST STUDIESUL1RR029876 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$17.7M
Mechanisms of Steroid Resistance in Severe AsthmaR01HL069130 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CALHOUN, WILLIAM J. · 2001 to 2005
$2.6M
Airway Remodeling in Severe AsthmaR01HL069149 · NHLBI · WASHINGTON UNIVERSITY · PI CASTRO, MARIO · 2001 to 2005
$2.5M
NHLBI PROTEOMICS INITIATIVE-N01HV28184N01HV028184 · HV · UNIV OF TEXAS MEDICAL BRANCH · PI KUROSKY, ALEXANDER NONE · 2002 to 2006
–
NCATS NIH HHS UL1 TR000005NCRR NIH HHS 1U54RR02614NCRR NIH HHS UL1 RR029876NHLBI NIH HHS BAA-HL-02-04NHLBI NIH HHS HL69130NHLBI NIH HHS HL69149NHLBI NIH HHS N01 HV028184NHLBI NIH HHS R01 HL069130NHLBI NIH HHS R01 HL069149NIAID NIH HHS AI062885NIAID NIH HHS P01 AI062885NIAID NIH HHS U19 AI070489NIEHS NIH HHS P30 ES006676NIEHS NIH HHS P30 ES06676
6 · The paper itself

Abstract

An important problem in realizing personalized medicine is the development of methods for identifying disease subtypes using quantitative proteomics. Recently we found that bronchoalveolar lavage (BAL) cytokine patterns contain information about dynamic lung responsiveness. In this study, we examined physiological data from 1,048 subjects enrolled in the US Severe Asthma Research Program (SARP) to identify four largely separable, quantitative intermediate phenotypes. Upper extremes in the study population were identified for eosinophil- or neutrophil-predominant inflammation, bronchodilation in response to albuterol treatment, or methacholine sensitivity. We evaluated four different statistical ("machine") learning methods to predict each intermediate phenotype using BAL A-cytokine measurements on a 76 subject subset. Comparison of these models using area under the ROC curve and overall classification accuracy indicated that logistic regression and multivariate adaptive regression splines produced the most accurate methods to predict intermediate asthma phenotypes. These robust classification methods will aid future translational studies in asthma targeted at specific intermediate phenotypes.

Indexed as

ProteomicsAdolescentAge of OnsetAsthmaBronchoalveolar Lavage FluidChildChild, PreschoolCytokinesEosinophilsFemaleHumansImmunophenotypingInfantLogistic ModelsMaleNeutrophilsCytokines

Identifiers

PMID20718815
PMCPMC3021493
OpenAlexW1987448351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.